NCT03710499

Brief Summary

Acromegaly is chronic, systemic and highly disabling disease. People with Acromegaly show a significant reduction in peripheral muscle strength associated with a loss resistance and lethargy. They tend the fatigue more easily when compared to individuals without the disease, which involves exercise intolerance and disability resulting in a quality of life impaired. Acromegaly have important functional limitations that adversely affect the performance in the activities of day-to-day and contribute to the worsening of the disease. Based on previous studies, the investigators believe that acromegaly participants with would have benefit from a treatment protocol facing physical performance and improved quality of life. Main Objective: To evaluate the effect of home rehabilitation on quality of life of participants with acromegaly. Methods: In this study of longitudinal intervention, they will undergo a rehabilitation program lasting three months, three times a week lasting 60 minutes each session. The protocol will be the assessment of Acromegaly Quality of Life Questionnaire (AcroQol) questionnaire, functional assessment by the walk test of six minutes (6MWT), peripheral muscle strength and assessment of joint integrity, fatigue will be measured by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire that evaluates the fatigue in the chronic participants. The assessment will be in 3 different moment (month 0, month 2 month 3). The treatment protocol will consist of warm-up and cool-down, strengthening exercise and muscular endurance, aerobic training, and balance training and proprioception. Prospects: The participants with acromegaly will benefited significantly after undergoing a physical therapy rehabilitation protocol the following parameters: Resistance and muscle strength, pain conditions and disorders skeletal muscle, improvement in activities of daily living and consequent better quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2016

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

October 10, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 18, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2019

Completed
Last Updated

October 23, 2018

Status Verified

October 1, 2018

Enrollment Period

3.7 years

First QC Date

October 10, 2018

Last Update Submit

October 19, 2018

Conditions

Keywords

AcromegalyRehabilitationPhysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Isometric dynamometry with surface electromyography

    Peripheral muscle strength and fatigue strength will be evaluated using an EMG -810 surface electromyograph and a DIN\_TRO traction dynamometer. For the strength test, the muscle evaluated will be the femoral quadriceps, the patient will be instructed to perform the knee extension, with the highest possible isometric force. Your positioning will be seated with your hands crossed over the chest, with the upright trunk adjusted by the backrest in order to allow the angle of 90 ° for hip flexion. For analysis of fatigue strength, surface electromyography of the medial vastus muscle (VM) of the dominant lower limb will be used through the 8-channel surface electromyograph from the gross signal. The endurance test consists of a contraction sustained for 60 seconds using 50% of the highest MIVM obtained in the strength test.

    eight weeks

Secondary Outcomes (1)

  • Walk test of six minutes (6MWT)

    eight weeks

Other Outcomes (5)

  • Acromegaly Quality of Life Questionnaire (AcroQol)

    eight weeks

  • Functional Assessment of Chronic Illness Therapy-Fatigue - (FACIT-F)

    eight weeks

  • Lower Extremity Functional Scale (LEFS)

    eight weeks

  • +2 more other outcomes

Study Arms (1)

Physical activity

EXPERIMENTAL

The program comprises the practice of resistance exercises for the main muscular groups, with free weights and with their own body weight against the action of gravity, the proposal consists of 3 weekly sessions, for 8 consecutive weeks.

Procedure: Physical activity

Interventions

Activities included overall stretching and strengthening (flexion, extension, adduction and abduction movements) and muscular endurance exercises (exercises involving open and closed kinetic chains), along with aerobic conditioning using a functional circuit.

Physical activity

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with acromegaly, of both sexes, older than 18 and younger than 65 years, either with active or controlled disease.
  • Patients who present clinical stability and who are eligible for the treatment protocol (patients with hormone deficiency will continue on replacement therapy - SILVA et al., 2013).
  • Signature of the Informed Consent Term (TCLE).

You may not qualify if:

  • Patients with inability to perform the 6MWT, according to ATS criteria.
  • Patients who have cognitive impairment by mini mental state examination (MEEN).
  • Abandonment of treatment during the application of the protocol.
  • Uncontrolled hypertension (\> 180/100 mmHg with medication use).
  • Use of psychotropic drugs.
  • Any significant limitations due to osteoarthropathy.
  • History of surgery in the previous year with exercise restriction. Não Untreated hypothyroidism or hypocortisolism (HUBBLE et al., 2014).
  • IPAQ with very active classification.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro universitário augusto motta

Rio de Janeiro, Rio de Janeiro, 21041-020, Brazil

RECRUITING

MeSH Terms

Conditions

AcromegalyMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Bone Diseases, EndocrineBone DiseasesMusculoskeletal DiseasesHyperpituitarismPituitary DiseasesHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Tatiana l Lima, Msc

    Centro Universitário Augusto Motta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tatiana L Lima, Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: After a physical therapy evaluation, the patient underwent a booklet-guided physical exercise program that lasted two months (3 times per week with a duration of 60 minutes per session). Activities included overall stretching and strengthening (flexion, extension, adduction and abduction movements) and muscular endurance exercises (exercises involving open and closed kinetic chains), along with aerobic conditioning using a functional circuit. The patient was evaluated at 3 different timepoints (baseline, after 8 weeks of training, and after a 4-week washout period with no treatment); thus, he served as his own control. The physiotherapist contacted the patient by phone weekly to follow the progression of the treatment. Throughout the application of the protocol, the patient regularly maintained his follow-up visits with the multidisciplinary team. Moreover, there was no change in pharmacological treatment throughout this period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2018

First Posted

October 18, 2018

Study Start

January 10, 2016

Primary Completion

September 10, 2019

Study Completion

October 10, 2019

Last Updated

October 23, 2018

Record last verified: 2018-10

Locations